Hand-foot skin reaction (HFSR) and overall survival (OS) in the phase 3 RESORCE trial of regorafenib for treatment of hepatocellular carcinoma (HCC) progressing on sorafenib

被引：0

作者：

Waldschmidt, D. ^{[1
]}

Merle, P. ^{[2
]}

Granito, A. ^{[3
]}

Huang, Y-H ^{[4
]}

Bodoky, G. ^{[5
]}

Yokosuka, O. ^{[6
]}

Rosmorduc, O. ^{[7
]}

Breder, V. V. ^{[8
]}

Gerolami, R. ^{[9
]}

Masi, G. ^{[10
]}

Ross, P. J. ^{[11
]}

Qin, S. ^{[12
]}

Song, T. ^{[13
]}

Bronowicki, J-P ^{[14
]}

Ollivier-Hourmand, I ^{[15
]}

Kudo, M. ^{[16
]}

Xu, L. ^{[17
]}

Baumhauer, A. ^{[18
]}

Meinhardt, G. ^{[17
]}

Han, G. ^{[19
]}

Bruix, J. ^{[20
]}

机构：

[1] Univ Klinikums Koln, Klin Gastroenterol & Hepatol, Cologne, Germany

[2] Grp Hosp Lyon Nord, Lyon, France

[3] Univ Bologne, Bologna, Italy

[4] Taipei Vet Hosp, Taipei, Taiwan

[5] St Laszlo Teaching Hosp, Budapest, Hungary

[6] Chiba Univ, Chiba, Japan

[7] Hop la Pitie Salpetriere, Paris, France

[8] Russian Canc Res Ctr, Moscow, Russia

[9] Univ Berne Mediterranee, Marseille, France

[10] Azienda Osped Univ Pisana, Pisa, Italy

[11] Kings Coll Hosp NHS Fdn Trust, London, England

[12] Chinese Peoples Liberat Army, Ctr Canc, Nanjing, Jiangsu, Peoples R China

[13] Tianjin Med Univ, Canc Hosp, Tianjin, Peoples R China

[14] CHU Nancy, INSERM 954, Nancy, France

[15] CHU Caen, Caen, France

[16] Kindai Univ, Fac Med, Osaka, Japan

[17] Bayer Pharmaceut Inc, Whippany, NJ USA

[18] Bayer Vital GmbH, Leverkusen, Germany

[19] Natl Clin Res Ctr Digest Dis, Xian, Shaanxi, Peoples R China

[20] Univ Barcelona, BCLC Grp, Liver Unit, Barcelona, Spain

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P875

引用

页码：281 / 281

页数：1